Hu Yan-Yan, Xu Fa-Wei, Wang Yong, Feng Zi-Xuan, Zhang Li-Yun, Zhao Wei, Chen Chun-Ye, Zhang Min-Xia, He Gui-Juan, Wang Shou-Jie, Tan Wei-Qiang
Department of Plastic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, P. R. China.
Department of Plastic Surgery, The Fourth Affiliated Hospital, Zhejiang University School of Medicine Yiwu, Zhejiang, P. R. China.
Am J Transl Res. 2023 Feb 15;15(2):1204-1214. eCollection 2023.
Scarring is a common but intricate problem, and topical anti-scarring drugs are the most widely used treatment. However, the wide range of drugs available makes it difficult for doctors and patients to choose from because of the lack of clinical comparisons. Therefore, we conducted an observational study to compare the clinical efficacy of different topical anti-scarring drugs.
Patients with post-suturing facial scars were enrolled in this study. The questionnaire was designed to record the basic characteristics of the patients. The Vancouver Scar Scale, SCAR scale, and measurements of scar width and thickness were used to evaluate scar quality. Patients who met the inclusion criteria were divided into four groups for comparison: the silicone preparation (SP), onion extract (OE), asiaticoside (AC) groups, and the untreated blank control (BC) group. The overall data were analyzed before they were confined to the zygomatic region.
A total of 127 eligible patients were enrolled in this study. The results of the total and zygomatic scars demonstrated that SP, OE, and AC groups resulted in narrower scars and lower scar scale scores. The SP group depicted higher melanin efficacy than the other two groups. The OE group had the best pliability, whereas the AC group had the thinnest scar.
In this study, we acquired expertise with different topical anti-scar agents: SP significantly reduced melanin levels, OE mainly benefited scar pliability, and AC was better at reducing scar thickness. These differences may be more instructive for clinical applications.
瘢痕形成是一个常见但复杂的问题,局部抗瘢痕药物是最广泛使用的治疗方法。然而,由于缺乏临床比较,市面上种类繁多的药物让医生和患者难以选择。因此,我们进行了一项观察性研究,以比较不同局部抗瘢痕药物的临床疗效。
本研究纳入了面部缝合后有瘢痕的患者。设计问卷以记录患者的基本特征。使用温哥华瘢痕量表、SCAR量表以及瘢痕宽度和厚度测量来评估瘢痕质量。符合纳入标准的患者被分为四组进行比较:硅酮制剂(SP)组、洋葱提取物(OE)组、积雪草苷(AC)组和未治疗的空白对照组(BC)组。在将总体数据局限于颧部区域之前进行分析。
本研究共纳入127例符合条件的患者。总体瘢痕和颧部瘢痕的结果表明,SP组、OE组和AC组的瘢痕更窄,瘢痕量表评分更低。SP组的黑色素去除效果高于其他两组。OE组的柔韧性最佳,而AC组的瘢痕最薄。
在本研究中,我们获得了不同局部抗瘢痕药物的相关专业知识:SP能显著降低黑色素水平,OE主要改善瘢痕柔韧性,AC在减少瘢痕厚度方面效果更佳。这些差异可能对临床应用更具指导意义。